Cardiovascular Drugs — MCQs

Cardiovascular Drugs Indian Medical PG Practice Questions and MCQs

Question 231: Which of the following drugs can be used to treat hypertension induced by cyclosporine?

A. Clonidine
B. Enalapril (Correct Answer)
C. Nifedipine
D. Methyldopa

Explanation: **Explanation:** The correct answer is **B. Enalapril**. **Mechanism and Rationale:** Cyclosporine, a calcineurin inhibitor used for immunosuppression, frequently causes hypertension as a side effect. The primary mechanism behind cyclosporine-induced hypertension is **systemic vasoconstriction** and **activation of the Renin-Angiotensin-Aldosterone System (RAAS)**. Cyclosporine increases the production of Endothelin-1 (a potent vasoconstrictor) and decreases the production of vasodilatory prostaglandins. Since RAAS activation is a hallmark of this condition, **ACE inhibitors (like Enalapril)** or Angiotensin Receptor Blockers (ARBs) are the preferred agents to counteract these effects and provide nephroprotection. **Analysis of Incorrect Options:** * **A. Clonidine & D. Methyldopa:** These are centrally acting alpha-2 agonists. While they lower blood pressure, they do not address the specific RAAS-mediated pathophysiology of cyclosporine-induced hypertension and are not first-line choices. * **C. Nifedipine:** While Calcium Channel Blockers (CCBs) are effective in treating cyclosporine-induced hypertension, **Dihydropyridines (like Nifedipine)** should be used with caution. More importantly, non-dihydropyridines (Verapamil/Diltiazem) are generally avoided because they inhibit Cytochrome P450 (CYP3A4), leading to toxic levels of cyclosporine. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** ACE inhibitors/ARBs are preferred for cyclosporine-induced hypertension, especially in renal transplant patients, due to their ability to reduce efferent arteriolar resistance. * **Gingival Hyperplasia:** Both Cyclosporine and Nifedipine can cause gingival hyperplasia; using them together significantly increases this risk. * **Monitoring:** Always monitor serum potassium levels when using Enalapril with Cyclosporine, as both drugs can cause **hyperkalemia**.

Question 232: Which anti-adrenergic drug crosses the blood-brain barrier minimally?

A. Propranolol
B. Atenolol (Correct Answer)
C. Oxprenolol
D. Alprenolol

Explanation: **Explanation:**The ability of a drug to cross the blood-brain barrier (BBB) is primarily determined by its **lipophilicity** [2]. Beta-blockers are categorized based on their lipid solubility, which dictates their central nervous system (CNS) penetration and side-effect profile.**1. Why Atenolol is the Correct Answer:**Atenolol is a **highly hydrophilic (water-soluble)**, second-generation $eta_1$-selective blocker [2]. Due to its low lipid solubility, it crosses the BBB minimally [2]. This property makes it the preferred choice for patients who experience CNS side effects (like insomnia, vivid dreams, or depression) with other beta-blockers. It is primarily excreted unchanged by the kidneys [1].**2. Analysis of Incorrect Options:*** **Propranolol (Option A):** This is a highly **lipophilic** non-selective beta-blocker [2]. It crosses the BBB rapidly and extensively, which is why it is effective for migraine prophylaxis and performance anxiety, but frequently causes CNS side effects like sedation and nightmares [2].* **Oxprenolol (Option C) & Alprenolol (Option D):** Both are non-selective beta-blockers with **moderate to high lipophilicity**. They penetrate the CNS significantly more than atenolol [2].**3. High-Yield Clinical Pearls for NEET-PG:*** **Lipophilic Beta-blockers:** Propranolol, Metoprolol, Labetalol, Carvedilol (High CNS penetration) [2].* **Hydrophilic Beta-blockers:** Atenolol, Sotalol, Nadolol (Minimal CNS penetration) [2].* **Metabolism:** Lipophilic drugs are generally metabolized by the **liver** (shorter half-life), while hydrophilic drugs are excreted by the **kidneys** (longer half-life) [1].* **Clinical Choice:** Use Atenolol in patients with liver disease; use Propranolol/Metoprolol in patients with renal failure.

Question 233: Which of the following antihypertensives does not have any central action?

A. Propranolol
B. Methyldopa
C. Minoxidil
D. Nitroprusside (Correct Answer)

Explanation: ### Explanation The correct answer is **Nitroprusside**. This question tests your understanding of the site of action of various antihypertensive agents, specifically distinguishing between centrally acting drugs and peripheral vasodilators. **1. Why Nitroprusside is correct:** Sodium Nitroprusside is a **purely peripheral vasodilator**. It acts by releasing Nitric Oxide (NO), which stimulates guanylyl cyclase to increase cGMP levels in vascular smooth muscle. This leads to immediate relaxation of both arterioles and venules. Crucially, Nitroprusside is highly ionized and does not cross the blood-brain barrier in significant amounts to exert a central antihypertensive effect. **2. Why the other options are incorrect:** * **Propranolol (Option A):** As a highly lipophilic beta-blocker, it easily crosses the blood-brain barrier. While its primary effect is peripheral (decreased cardiac output and renin), it also has a **central action** by inhibiting sympathetic outflow from the brainstem. * **Methyldopa (Option B):** This is a classic **centrally acting** antihypertensive. It is a prodrug converted to alpha-methylnorepinephrine, which stimulates central $\alpha_2$ receptors in the nucleus tractus solitarius, reducing sympathetic tone. * **Minoxidil (Option C):** While primarily a peripheral K+ channel opener, Minoxidil is known to have some central effects, including the stimulation of central sympathetic discharge (reflex tachycardia) and potential modulation of central cardiovascular centers. **3. NEET-PG High-Yield Pearls:** * **Nitroprusside:** Drug of choice for hypertensive emergencies (though being replaced by Fenoldopam/Labetalol in some protocols). Watch for **Cyanide toxicity** with prolonged use (treated with Sodium Thiosulfate). * **Methyldopa:** The traditional drug of choice for hypertension in **pregnancy**. Common side effect: Positive Coombs test/Hemolytic anemia. * **Centrally acting drugs:** Clonidine and Methyldopa are the prototypes. Sudden withdrawal of Clonidine causes "rebound hypertension."

Question 234: Which of the following drugs or combination of drugs would be a suitable alternative to dobutamine for treating acute cardiac failure, providing a pharmacologic equivalent effect?

A. Dopamine at a high dose
B. Ephedrine plus propranolol
C. Norepinephrine plus phentolamine (Correct Answer)
D. Methoxamine plus atropine

Explanation: To understand this question, we must first analyze the pharmacological profile of **Dobutamine**. Dobutamine is a selective **$\beta_1$ agonist** with mild $\beta_2$ and $\alpha_1$ activity. Its net clinical effect in acute heart failure is **positive inotropy** (increased contractility) with minimal change in peripheral vascular resistance (due to balanced $\alpha_1$ constriction and $\beta_2$ dilation). ### Why Option C is Correct **Norepinephrine** is a potent agonist at $\alpha_1$ and $\beta_1$ receptors. While it increases cardiac contractility ($\beta_1$), its powerful $\alpha_1$ effect causes intense vasoconstriction, which increases afterload and is detrimental in heart failure. By adding **Phentolamine** (a non-selective $\alpha$-blocker), the vasoconstrictive $\alpha_1$ effects are neutralized. This leaves the **$\beta_1$ stimulatory effect** of Norepinephrine unopposed, effectively mimicking the selective inotropic action of Dobutamine. ### Why Other Options are Incorrect * **A. Dopamine (High dose):** At high doses (>10 $\mu$g/kg/min), dopamine predominantly stimulates $\alpha_1$ receptors, causing significant vasoconstriction and increasing cardiac workload, unlike the balanced profile of dobutamine. * **B. Ephedrine plus Propranolol:** Propranolol is a non-selective $\beta$-blocker. Adding it would block the very $\beta_1$ receptors needed to improve cardiac output, potentially worsening heart failure. * **C. Methoxamine plus Atropine:** Methoxamine is a pure $\alpha_1$ agonist (vasoconstrictor). Atropine blocks vagal tone. This combination lacks $\beta_1$ agonism and would increase afterload without directly improving contractility. ### High-Yield NEET-PG Pearls * **Dobutamine** is the drug of choice for **cardiogenic shock** because it increases cardiac output without significantly increasing heart rate or oxygen demand compared to other inotropes. * **Isoprenaline** is a pure $\beta_1 + \beta_2$ agonist; it increases CO but often causes marked tachycardia and hypotension. * **Norepinephrine** is the first-line vasopressor for **septic shock**, where peripheral vasodilation is the primary issue.

Question 235: Epinephrine increases heart rate by its action on which of the following?

A. Calmodulin
B. Calsequestrin
C. Calreticulin
D. Phospholamban (Correct Answer)

Explanation: **Explanation:** Epinephrine (Adrenaline) increases heart rate (positive chronotropy) and contractility (positive inotropy) primarily by stimulating **$\beta_1$-adrenergic receptors** in the myocardium. **Mechanism of Action:** 1. Stimulation of $\beta_1$ receptors activates **Adenyl Cyclase**, increasing intracellular **cAMP**. 2. cAMP activates **Protein Kinase A (PKA)**. 3. PKA phosphorylates **Phospholamban**, a protein that normally inhibits the **SERCA** (Sarcoplasmic Reticulum Ca²⁺-ATPase) pump. 4. Once phosphorylated, Phospholamban's inhibitory effect is removed, allowing SERCA to rapidly sequester calcium back into the sarcoplasmic reticulum. 5. This accelerates relaxation (lusitropy) and increases the calcium "load" available for the next contraction, leading to an increased heart rate and force. **Analysis of Incorrect Options:** * **A. Calmodulin:** A calcium-binding messenger protein that mediates various cellular processes (like smooth muscle contraction) but is not the primary target for epinephrine’s chronotropic effect. * **B. Calsequestrin:** A calcium-binding protein located *inside* the sarcoplasmic reticulum that helps store high concentrations of Ca²⁺; it does not regulate the rate of contraction via the $\beta$-pathway. * **C. Calreticulin:** A multifunctional protein that acts as a calcium buffer in the *endoplasmic* reticulum; it is not involved in the acute adrenergic regulation of heart rate. **High-Yield Clinical Pearls for NEET-PG:** * **Lusitropy:** The term for myocardial relaxation. Phospholamban phosphorylation is the key mediator of catecholamine-induced lusitropy. * **SERCA2:** The specific isoform of the calcium pump found in cardiac muscle. * **Inamrinone/Milrinone:** These PDE3 inhibitors increase cAMP levels, mimicking the effect of epinephrine on phospholamban, used in acute heart failure.

Question 236: All of the following drugs can be used in hypertensive emergency except:

A. Trimethaphan
B. IV hydralazine
C. Indapamide (Correct Answer)
D. Sublingual nifedipine

Explanation: **Explanation:** A **hypertensive emergency** is defined as a severe elevation in blood pressure (>180/120 mmHg) accompanied by evidence of acute target organ damage (e.g., encephalopathy, MI, or acute renal failure). Management requires **parenteral (IV)** drugs for rapid, controlled reduction of blood pressure. **Why Indapamide is the correct answer:** Indapamide is a **thiazide-like diuretic** administered **orally**. It has a slow onset of action and is primarily used for the long-term maintenance treatment of essential hypertension. It has no role in acute settings like a hypertensive emergency where immediate BP reduction is mandatory. **Analysis of other options:** * **Trimethaphan:** A ganglion-blocking agent administered via IV infusion. Though rarely used today due to side effects, it was historically a mainstay for hypertensive emergencies and aortic dissection. * **IV Hydralazine:** A direct-acting vasodilator. It is frequently used in hypertensive emergencies, particularly in **pregnancy-induced hypertension (Eclampsia/Pre-eclampsia)**. * **Sublingual Nifedipine:** While no longer the first-line treatment due to the risk of unpredictable, precipitous drops in BP (potentially causing stroke or MI), it is pharmacologically capable of rapid BP reduction and has been used in emergency settings. **NEET-PG High-Yield Pearls:** 1. **Drug of Choice (DOC):** **Sodium Nitroprusside** was traditionally the DOC, but **Labetalol** or **Nicardipine** are now preferred in most clinical scenarios. 2. **Aortic Dissection:** The DOC is **Esmolol** (to reduce heart rate and shear stress). 3. **Pheochromocytoma:** Use **Phentolamine** (alpha-blocker). 4. **Goal of Therapy:** Reduce Mean Arterial Pressure (MAP) by no more than **25% within the first hour** to prevent cerebral ischemia.

Question 237: Which of the following drugs is most likely to precipitate angina?

A. Amlodipine
B. Nifedipine (Correct Answer)
C. Diltiazem
D. Verapamil

Explanation: **Explanation** The correct answer is **Nifedipine**. **1. Why Nifedipine is the correct answer:** Nifedipine is a short-acting **Dihydropyridine (DHP)** Calcium Channel Blocker (CCB). It is a potent peripheral vasodilator. When administered (especially in its immediate-release form), it causes a rapid drop in blood pressure, which triggers a powerful **baroreceptor-mediated sympathetic discharge**. This results in **reflex tachycardia** and increased myocardial contractility. The sudden increase in heart rate and oxygen demand, coupled with a potential "coronary steal" effect, can precipitate or worsen myocardial ischemia (angina). **2. Why the other options are incorrect:** * **Amlodipine:** While also a DHP, amlodipine has a very **long half-life** and a slow onset of action. Because the vasodilation is gradual, it does not trigger the same intense reflex tachycardia seen with short-acting nifedipine. * **Verapamil and Diltiazem:** These are **Non-Dihydropyridines**. Unlike DHPs, they have significant negative inotropic and chronotropic effects (they act directly on the heart). They decrease the heart rate and AV conduction, which actually helps in reducing myocardial oxygen demand, making them useful in treating stable angina rather than precipitating it. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Nifedipine Paradox":** Short-acting nifedipine is contraindicated in the management of hypertensive emergencies and acute MI because it increases the risk of mortality due to reflex tachycardia. * **Drug of Choice:** For **Prinzmetal (Variant) Angina**, CCBs (like Nifedipine or Diltiazem) are the drugs of choice because they relieve coronary vasospasm. * **Side Effects:** Common DHP side effects include ankle edema, flushing, and headache due to vasodilation.

Question 238: What is the antihypertensive of choice for a hypertensive diabetic patient with proteinuria?

A. Propranolol
B. Clonidine
C. Enalaprilat (Correct Answer)
D. Alpha-methyldopa

Explanation: **Explanation:** **1. Why Enalaprilat is the Correct Answer:** In patients with diabetes mellitus and hypertension, **ACE inhibitors (ACEIs)** like Enalaprilat (the active metabolite of Enalapril) are the drugs of choice. The underlying medical concept is **Renoprotection**. ACEIs dilate the efferent arteriole more than the afferent arteriole in the kidney. This reduces intraglomerular capillary pressure, thereby decreasing **proteinuria** and slowing the progression of diabetic nephropathy. They also improve insulin sensitivity, making them metabolic-neutral or beneficial. **2. Why the Other Options are Incorrect:** * **Propranolol (Beta-blocker):** Generally avoided as a first-line agent in diabetics because it can mask the warning symptoms of hypoglycemia (tachycardia, tremors) and may worsen glycemic control by inhibiting insulin release. * **Clonidine (Alpha-2 agonist):** A centrally acting drug used primarily for resistant hypertension. It has no specific renoprotective benefits and is associated with side effects like sedation and dry mouth. * **Alpha-methyldopa:** This is the drug of choice for hypertension in **pregnancy**. It is not preferred for diabetic patients as it lacks the specific antiproteinuric effects of ACEIs. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** ACEIs or ARBs (Angiotensin Receptor Blockers) are the DOC for hypertension with Diabetes, Chronic Kidney Disease (CKD), and Heart Failure. * **Side Effects of ACEIs:** Remember the mnemonic **CAPTOPRIL** (Cough, Angioedema, Proteinuria/Potassium excess, Taste changes, Orthostatic hypotension, Pregnancy contraindication, Renal artery stenosis contraindication, Increased renin, Leukopenia). * **Contraindication:** ACEIs/ARBs are strictly contraindicated in **bilateral renal artery stenosis** (can cause acute renal failure) and **pregnancy** (teratogenic).

Question 239: Renolazine is used in the management of which condition?

A. Angina (Correct Answer)
B. Hypertension
C. Tachycardia
D. Arrhythmia

Explanation: **Explanation:** **Ranolazine** is a novel anti-anginal drug used primarily in the management of **chronic stable angina**. **Why Angina is Correct:** The core mechanism of Ranolazine involves the **selective inhibition of the late inward sodium current ($I_{Na}$)** in myocardial cells. During ischemia, there is an excess influx of sodium through these channels, which leads to an overload of intracellular calcium (via the $Na^+/Ca^{2+}$ exchanger). High calcium levels cause wall stiffness and increased diastolic tension, further compromising coronary blood flow. By blocking the late $I_{Na}$, Ranolazine reduces calcium overload, improves myocardial relaxation (diastolic function), and enhances coronary perfusion without significantly affecting heart rate or blood pressure. **Why Other Options are Incorrect:** * **Hypertension:** Ranolazine has negligible effects on systemic blood pressure and is not indicated for hypertension. * **Tachycardia:** Unlike beta-blockers or calcium channel blockers, Ranolazine does not significantly reduce the heart rate. * **Arrhythmia:** While Ranolazine can cause a modest prolongation of the **QT interval** (by blocking $I_{Kr}$ channels), it is not used as a primary anti-arrhythmic agent. In fact, its effect on the QT interval requires cautious monitoring. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** It is metabolized by **CYP3A4**; therefore, it is contraindicated with potent inhibitors like ketoconazole or clarithromycin. * **Unique Feature:** It is a "p-FOX inhibitor" (partial fatty acid oxidation inhibitor), shifting myocardial metabolism from fatty acids to glucose, which requires less oxygen. * **Usage:** It is typically used as a **second-line** add-on therapy when symptoms are not controlled by first-line agents (Beta-blockers/CCBs). * **Side Effects:** Dizziness, headache, constipation, and QT prolongation.

Question 240: Which one of the following drugs is most commonly employed in an attack of angina pectoris?

A. Sodium nitrate
B. Epinephrine
C. Nitroglycerin (Correct Answer)
D. Isosorbide dinitrate

Explanation: **Nitroglycerin (Glyceryl Trinitrate - GTN)** is the drug of choice for the acute management of an angina pectoris attack [1]. The primary mechanism involves the release of **nitric oxide (NO)**, which activates guanylyl cyclase, increasing cGMP levels and leading to vascular smooth muscle relaxation [1]. While it dilates both arteries and veins, its predominant effect at therapeutic doses is **venodilation**, which reduces venous return (preload) and decreases myocardial oxygen demand. **Analysis of Options:** * **Nitroglycerin (C):** It is preferred due to its rapid onset of action (1–3 minutes) when administered **sublingually**, bypassing first-pass metabolism [1]. This makes it ideal for terminating an acute attack. * **Sodium nitrate (A):** This is not used for angina. Sodium nitrite (not nitrate) is used in the management of cyanide poisoning to induce methemoglobinemia. * **Epinephrine (B):** This is contraindicated in angina. As a sympathomimetic, it increases heart rate and contractility, significantly raising myocardial oxygen demand, which can worsen ischemia or trigger an MI. * **Isosorbide dinitrate (D):** While used for angina, it has a slower onset of action compared to sublingual GTN [1]. It is more commonly used for the **prophylaxis** (prevention) of attacks rather than the immediate termination of an acute episode [1], [2]. **High-Yield NEET-PG Pearls:** * **Storage:** GTN is volatile and light-sensitive; it must be stored in tightly closed, dark glass containers. * **Tolerance:** Continuous exposure leads to "nitrate tolerance" (attenuation of effect) [1]. A **nitrate-free interval** of 8–12 hours (usually at night) is required to restore sensitivity [2]. * **Monday Disease:** Workers in dynamite factories exposed to nitrates during the week experienced headaches that disappeared over the weekend, only to return on Monday due to loss of tolerance. * **Contraindication:** Never co-administer with **Sildenafil** (PDE-5 inhibitors) as it can cause life-threatening hypotension.

Practice by Chapter

Antihypertensive Agents

Practice Questions

Drugs for Heart Failure

Practice Questions

Antiarrhythmic Drugs

Practice Questions

Antianginal Agents

Practice Questions

Lipid-Lowering Drugs

Practice Questions

Anticoagulants and Antiplatelet Drugs

Practice Questions

Thrombolytic Agents

Practice Questions

Drugs Used in Pulmonary Hypertension

Practice Questions

Drugs Used in Shock

Practice Questions

Cardiovascular Effects of Non-Cardiovascular Drugs

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free